Genomics sells instruments, consumables and services used to analyze biological information. Read why TXG stock is upgraded ...
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available in the world ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx will ...
LatchBio provides white-labeled data infrastructure, analysis tools and delivery portals for kit, instrument, and solution providers. Today, LatchBio released a 25 million cell spatial atlas spanning ...
“Illumina’s…presentations and product descriptions revealed a workflow that infringed on the ‘607, ‘138, ‘505, and ‘487 patents, 10x Genomics and Prognosys Biosciences argued.” On October 21, 10x ...
Precision medicine company CareDx and 10x Genomics have partnered to launch ImmuneScape, a multiomics program to improve the understanding of transplant organ rejection and variability in patient ...
• Troy Randall – Med – Clinical Immunology and Rheumatology - The epigenetic modifier Kmt2a regulates humoral responses to influenza by orchestrating B cell function in the pre-inducible ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results